MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.
Testicular cancer is one of the most common cancers affecting young men, especially those between the ages of 20 and 40.
A simple, cheap and widely available chemist item may have been overlooked for its potential as a DIY home test for cancer ...
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...
Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...
Do you build tall emotional walls? Or do you wear your heart on your sleeve? Take this test to find out how you guard the most vulnerable parts of yourself.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results